Suven Life Sciences Limited

Srinivasa Rao Ravella

Venkateswarlu Jasti

Ramakrishna Nirogi

Anil Karbhari Shinde

Abdul Rasheed Mohammed

Pradeep Jayarajan

Gopinadh Bhyrapuneni

Ramasastri Kambhampati

Jyothsna Ravula

Sriramachandra Murthy Patnala

Suresh Yarlagadda

Praveen Kumar Roayapalley

Ishtiyaque Ahmad

Ramkumar Subramanian

Srinivas Veeramalla

Rama Sastri Kambhampti

Abdul Rashee Mohammed

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt(s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of such compounds. (I)

Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators

The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them.  The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HTreceptors.

[object Object]

The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment and prevention of various disorders that are related to &#x3b1;&#x3b2;nicotinic receptors. 

Growing community of inventors

Andhra Pradesh, India

Srinivasa Rao Ravella